Covered recipient · General Payments record
XELENIA DEPENA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2023
$376.88
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $154.41 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $44.73 | 2 |
| Lilly USA, LLC | $34.00 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.32 | 2 |
| GlaxoSmithKline, LLC. | $16.00 | 1 |
| Acerta Pharma LLC | $14.37 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $12.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.37 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011962219 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.94 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996410085 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.38 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996410081 | CMS |
| Exact Sciences Corporation | $21.02 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026682069 | CMS |
| Exact Sciences Corporation | $23.71 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026682125 | CMS |
| GlaxoSmithKline, LLC. | $16.00 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000951577 | CMS |
| Lilly USA, LLC | $17.16 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032652833 | CMS |
| Lilly USA, LLC | $16.84 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032510875 | CMS |
| Novartis Pharmaceuticals Corporation | $12.99 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991517181 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.